Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022:2573:249-259.
doi: 10.1007/978-1-0716-2707-5_19.

Ex Vivo Delivery of Viral Vectors by Organ Perfusion for Cardiac Transplantation Gene Therapy

Michelle Mendiola Pla  1 , Amy Evans  1 , Paul Lezberg  2 , Dawn E Bowles  3
Affiliations

Ex Vivo Delivery of Viral Vectors by Organ Perfusion for Cardiac Transplantation Gene Therapy

Michelle Mendiola Pla et al. Methods Mol Biol. 2022.

Abstract

Recent advances in ex vivo perfusion have enabled an extended preservation time for solid organs prior to transplantation allowing for possible resuscitation of the donor organ during the preservation period. Opportunities to provide viral vector-mediated gene therapy to the entire cardiac graft during this extended preservation period may lead to improvements in cardiac transplantation outcomes. Here we describe how to achieve successful gene delivery using viral vectors to an entire cardiac graft by normothermic, ex vivo perfusion. This protocol has been confirmed with the most highly utilized viral vector types in gene therapy clinical studies (adenoviral [Ad] and adeno-associated viral vector [AAV]).

Keywords: Cardiac transplantation; Ex vivo perfusion; Gene delivery; Gene therapy; Viral vectors.

PubMed Disclaimer

References

    1. Sahoo S, Kariya T, Ishikawa K (2021) Targeted delivery of therapeutic agents to the heart. Nat Rev Cardiol 18(6):389–399. https://doi.org/10.1038/s41569-020-00499-9 - DOI
    1. Vassalli G, Roehrich M-E, Vogt P, Pedrazzini GB, Siclari F, Moccetti T, Von Segesser LK (2009) Modalities and future prospects of gene therapy in heart transplantation. Eur J Cardiothorac Surg 35(6):1036–1044. https://doi.org/10.1016/j.ejcts.2009.01.044 - DOI
    1. Miyagi N, Rao VP, Ricci D, Du Z, Byrne GW, Bailey KR, Nakai H, Russell SJ, McGregor CGA (2008) Efficient and durable gene transfer to transplanted heart using adeno-associated virus 9 vector. J Heart Lung Transplant 27(5):554–560. https://doi.org/10.1016/j.healun.2008.01.025 - DOI
    1. Abunasra HJ, Smolenski RT, Yap J, Sheppard M, O’Brien T, Yacoub MH (2003) Multigene adenoviral therapy for the attenuation of ischemia-reperfusion injury after preservation for cardiac transplantation. J Thorac Cardiovasc Surg 125(5):998–1006. https://doi.org/10.1067/mtc.2003.263 - DOI
    1. Bishawi M, Roan JN, Milano CA, Daneshmand MA, Schroder JN, Chiang Y, Lee FH, Brown ZD, Nevo A, Watson MJ, Rowell T, Paul S, Lezberg P, Walczak R, Bowles DE (2019) A normothermic ex vivo organ perfusion delivery method for cardiac transplantation gene therapy. Sci Rep 9(1):8029. https://doi.org/10.1038/s41598-019-43737-y - DOI

LinkOut - more resources